Pieris Pharmaceuticals Inc (PIRS)
15.64
+0.20
(+1.29%)
USD |
NASDAQ |
Nov 19, 13:40
Pieris Pharmaceuticals Price: 15.64 for Nov. 19, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 18, 2024 | 15.53 | 16.09 | 15.37 | 15.44 | 31384.00 |
Nov 15, 2024 | 15.85 | 16.14 | 15.79 | 15.87 | 6405.00 |
Nov 14, 2024 | 16.25 | 16.97 | 15.85 | 15.95 | 96583.00 |
Nov 13, 2024 | 16.47 | 16.85 | 16.01 | 16.10 | 97178.00 |
Nov 12, 2024 | 15.84 | 16.54 | 15.72 | 16.12 | 60219.00 |
Nov 11, 2024 | 16.84 | 16.88 | 15.69 | 15.97 | 40814.00 |
Nov 08, 2024 | 16.48 | 16.83 | 16.10 | 16.83 | 6141.00 |
Nov 07, 2024 | 16.55 | 16.69 | 16.36 | 16.48 | 6544.00 |
Nov 06, 2024 | 17.06 | 17.70 | 16.55 | 16.70 | 273309.0 |
Nov 05, 2024 | 16.95 | 17.26 | 16.88 | 17.00 | 14248.00 |
Nov 04, 2024 | 17.21 | 17.35 | 16.97 | 16.98 | 18582.00 |
Nov 01, 2024 | 17.25 | 17.47 | 17.10 | 17.30 | 4608.00 |
Oct 31, 2024 | 17.00 | 17.33 | 16.72 | 17.25 | 6691.00 |
Oct 30, 2024 | 16.90 | 16.90 | 16.51 | 16.87 | 5884.00 |
Oct 29, 2024 | 17.00 | 17.20 | 17.00 | 17.00 | 5538.00 |
Oct 28, 2024 | 16.75 | 17.00 | 16.70 | 17.00 | 12326.00 |
Oct 25, 2024 | 16.51 | 16.99 | 16.51 | 16.94 | 1158.00 |
Oct 24, 2024 | 16.55 | 17.00 | 16.55 | 17.00 | 10162.00 |
Oct 23, 2024 | 16.50 | 16.95 | 16.38 | 16.95 | 12254.00 |
Oct 22, 2024 | 16.63 | 16.83 | 16.35 | 16.42 | 23533.00 |
Oct 21, 2024 | 16.91 | 16.91 | 16.66 | 16.80 | 2314.00 |
Oct 18, 2024 | 16.85 | 16.92 | 16.85 | 16.92 | 2842.00 |
Oct 17, 2024 | 16.71 | 16.96 | 16.52 | 16.93 | 3046.00 |
Oct 16, 2024 | 16.36 | 16.50 | 16.23 | 16.49 | 3443.00 |
Oct 15, 2024 | 16.11 | 16.40 | 16.09 | 16.25 | 9248.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
6.53
Minimum
Jul 11 2024
468.00
Maximum
Sep 17 2021
154.04
Average
150.40
Median
May 14 2021
Price Benchmarks
Ligand Pharmaceuticals Inc | 111.38 |
NovaBay Pharmaceuticals Inc | 0.6998 |
Palatin Technologies Inc | 0.96 |
iBio Inc | 2.16 |
Theriva Biologics Inc | 1.30 |
Price Related Metrics
PS Ratio | 0.4785 |
Price to Book Value | 1.104 |
Earnings Yield | -119.6% |
Market Cap | 20.65M |